KRAS and lung cancer: Furthermore, CFI‐402257 was recently found to restore anti‐PD‐1 efficacy in a model of KRAS‐LKB1‐mutant lung cancer, which are intrinsically resistant to PD‐1 blockade via epigenetic abrogation of STING.234